A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation?

Blood Cells, Molecules, and Diseases

Volumn 31, Issue 2, 2003, Pages 262-267

  Lucotte, Gérard ^a,b   Dieterlen, Florent ^a  

^a Intl Institute of Anthropology   (France)

^b Centre de Neurogenetique Moleculaire   (France)

Author keywords

C282Y allele map; C282Y frequencies; C282Y mutation; Celtic and Viking origins; Hemochromatosis; HFE gene; Populations in Europe

Indexed keywords

ALLELE; ARTICLE; EUROPE; GENE FREQUENCY; GENE MAPPING; GENE MUTATION; HEMOCHROMATOSIS; HEREDITY; HUMAN; IRELAND; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; SCANDINAVIA; UNITED KINGDOM; CONTROLLED STUDY; FRANCE; GENE CONSTRUCT; GENETIC DISORDER; MAJOR CLINICAL STUDY; SAMPLING;

HFE PROTEIN;

EID: 0346753577     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00133-5     Document Type: Article

References (62)

1. Feder J., Gnirke A., Thomas W., et al. A novel MHC class-I like gene is mutated in patients with hereditary hemochromatosis. Nat. Genet. 13:1996;399-408.
2. Merryweather-Clarke A., Pointon J., Shearman J., Robson K. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34:1997;275-278.
3. Simon M., Alexandre J.L., Fauchet R., Genetet B., Bourel M. The genetics of hemochromatosis. Prog. Med. Genet. 4:1980;135-168.
4. Mercier G., Bathelier C., Lucotte G. Frequency of the C282Y mutation of hemochromatosis in five French populations. Blood Cells Mol. Dis. 24:1998;165-166.
5. Lucotte G. Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol. Dis. 24:1998;433-438.
6. Lucotte G. Frequency analysis and allele map in favor of the Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol. Dis. 27:2001;549-556.
7. Merryweather-Clarke A., Simonsen H., Shearman J., et al. A retrospective anonymous pilot study in screening new-borns for HFE mutations in Scandinavian populations. Hum. Mutat. 13:1999;154-159.
8. Distante S., Berg J., Lande K., Haug E., Bell H. High prevalence of hemochromatosis-associated Cys282Tyr HFE gene mutation in healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand. J. Gastroenterol. 5:1999;530-534.
9. Beckman L., Saha N., Spitsyn V., Van Landeghem G., Beckman L. Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism. Hum. Hered. 47:1997;263-267.
10. Parkkila S., Niemelä O., Sovalainen E., Koistinen P. HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia. Transf. Med. 41:2001;828-831.
11. Pärlist P., Mikelsaar A., Tasa G., Beckman L. The frequency of C282Y and H63D mutations in hemochromatosis gene in native Estonians. Eur. J. Epidemiol. 17:2001;213-216.
12. Steffensen R., Varming K., Jersild C. Determination of gene frequencies for two common hemochromatosis mutations in the Danish population. Tissue Ant. 52:1998;230-235.
13. Simonsen K., Dissing J., Rudbeck L., Swartz M. Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP detection for a new polymorphic mutation . Ann. Hum. Genet. 63:1999;193-197.
14. Ryan E., O'Keane C., Growe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol. Dis. 25:1998;428-432.
15. Murphy S., Curran M., Mcdougall N., et al. High incidence of the Cys282Tyr mutation in the HFE gene in the Irish population - implications for hemochromatosis. Tissue Ant. 52:1998;484-488.
16. Miedzybrodka Z., Loughlin S., Baty D., et al. Haemochromatosis mutations in north-east Scotland. Br. J. Haematol. 106:1999;385-387.
17. Willis G., Jennings B., Goodman E., Fellows I., Winperis J. A high prevalence of HLA-H 845 A mutations in hemochromatosis patients and the normal population of eastern England. Blood Cells Mol. Dis. 23:1997;288-291.
18. Grove J., Daly A., Burt A., et al. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut. 43:1998;262-266.
19. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut. 41:1997;841-844.
20. Wallace D., Dooley J., Walker A. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology. 116:1999;1409-1412.
21. Merryweather-Clarke A., Worwood M., Parkinson L., et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br. J. Haematol. 101:1998;369-373.
22. Roest M., Van Der Schouw Y., de Valk B. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation. 100:1999;1268-1273.
23. Nielsen P., Carpinteiro S., Fischer R., et al. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary hemochromatosis and in control subjects from Northern Germany. Br. J. Haematol. 103:1998;842-845.
24. Gottschalk R., Seidl C., Löffer T., et al. HFE codon 63/282 (H63D/C282Y) dimorphisms in German patients with genetic hemochromatosis. Tissue Ant. 51:1998;270-275.
25. Datz C., Lalloz M., Vogel W., et al. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic hemochromatosis. J. Hepatol. 27:1977;773-779.
26. Tordai A., Andrikovics H., Kalmer L., et al. High frequency of the hemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation. J. Med. Genet. 35:1998;878-879.
27. Szakony S., Balogh I., Muszbek L. The frequency of the haemochromatosis C282Y mutation in the ethnic Hungarian and Romany populations of eastern Hungary. Br. J. Haematol. 107:1999;464-465.
28. Ivanova A., Von Ahsen N., Adjarov D., et al. C282Y and H63D mutations in the HFE gene are not associated with porphyria curanea tarda in Bugaria. Hepatology. 30:1999;1531-1532.
29. Jouanolle A., Fergelot P., Gandon G., et al. A candidate gene for hemochromatosis frequency of the C282Y and H63D mutations. Hum. Genet. 100:1997;544-547.
30. Mura C., Nousbaum J., Verger P., et al. Phenotype-genotype correlation in haemochromatosis subjects. Hum. Genet. 101:1997;271-276.
31. Jézéquel P., Bargain M., Lellouche F., Geffroy F., Dorval I. Allelle frequencies of hereditary hemochromatosis gene mutations in a local population of West Brittany. Hum. Genet. 102:1998;332-333.
32. Borot N., Roth M., Malfroy L., et al. Mutations in the MHC class I candidate gene for hemochromatosis in French patients. Immunogenetics. 45:1977;320-324.
33. Martinez P., Jeanjean P., Masmejean C., et al. Simple and rapid detection of the newly described mutations in the HLA-H gene. Blood. 89:1997;1835-1836.
34. Piperno A., Sampietro M., Pietrangelo A., et al. Heterozygosity of hemochromatosis in Italy. Gastroenterology. 114:1998;996-1002.
35. Sampietro M., Piperno A., Lupica L., et al. High prevalence of the his63asp HFE mutation in Italian patients with poyphyria cutanea tarda. Hepatology. 27:1998;181-184.
36. Racchi O., Mangerini R., Rapezzi D., et al. Mutations of the HFE gene and risk of hepatocellular carcinoma. Blood Cells Dis. 25:1999;350-353.
37. Borgna-Pignatti C., Solinas A., Bombieri C., et al. the hemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated. Br. J. Haematol. 103:1998;813-816.
38. De Marco, F., Giardina, M., Matarazzo, M., et al., The C282Y mutation in a group of patients with hereditary hemochromatosis in southern Italy, in: 34th Meeting of the European Association for the Study of the Liver, Napoli, April 8-12, 1999, p. 284.
39. Campo S., Restuccia T., Villari D., et al. Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. Liver. 21:2001;233-236.
40. Lio D., Balistreri C., Colonna-Romano G., et al. Genes Immun. 3:2002;20-24.
41. Cardoso C., Oliveira P., Porto G., et al. Comparative study of the two more frequent HFE mutations (C282Y and H63D) significant different allelic frequencies between the North and South of Portugal . Eur. J. Hum. Genet. 9:2001;843-848.
42. Soto L., Vega A., Goyanes V., et al. Hemochromatosis in Galicia a Celtic influence . Clin. Genet. 57:2000;454-455.
43. De Juan M., Reta A., Gastiella A., et al. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur. J. Hum. Genet. 9:2001;961-964.
44. Sanchez M., Bruguera M., Bosch J., et al. Prevalence of the Cys 282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J. Hepatol. 29:1998;725-728.
45. Baiget M., Barcelo M., Gimferrer E. Frequency of the HFE C282Y and H63D mutations in distinct ethnic groups living in Spain. J. Med. Genet. 35:1998;701.
46. Enriquez De Salamanca R., Morales P., Castro M., et al. The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is His63Asp. Hepatology. 117:1999;819-820.
47. Guix P., Picornell A., Parera M., et al. Distribution of HFE C282Y and H63D mutations in the Balearic Islands (NE Spain). Clin. Genet. 61:2002;43-48.
48. Papanikolaou G., Politou M., Terpos E., et al. Hereditary hemochromatosis HFE mutation analysis in Greeks reveals genetic heterogeneity . Blood Cells Mol. Dis. 26:2000;163-168.
49. Smith B., Kantrowitz W., Grace N., et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation is Celtic origin a risk factor . Hepatology. 25:1997;1439-1446.
50. Lucotte G., Mercier G. Celtic origin of the C282Y mutation of hemochromatosis. Gen. Test. 4:2000;163-169.
51. Pozzato G., Zorat F., Nascimben F., et al. Haemochromatosis gene mutations in a clustered Italian population evidence of high prevalence in people of Celtic ancestry . Eur. J. Hum. Genet. 9:2001;445-451.
52. Candore G., Mantovani V., Balisteri C., et al. Frequency of the HFE gene mutations in five Italian populations. Blood Cells Mol. Dis. 29:2002;173-267.
53. Férec C., Audrezet M., Mercier B., et al. Detection of over 98% cystic fibrosis mutations in a Celtic population. Nat. Genet. 1:1992;188-191.
54. Treacy E., Byck S., Clow C., Scriver C. "Celtic" phenylketonuria chromosomes found ? Evidence of two regions of Quebec province. Eur. J. Hum. Genet. 1:1993;220-228.
55. Lucotte G., Hazout S. Geographic and ethnic distribution of the more frequent cystic fibrosis mutations in Europe show that founder effect is apparent for several mutant alleles. Hum. Biol. 67:1995;561-576.
56. Olsson, K., Ritter, B., Sandberg, L., et al., The ancestral haplotype in patients with genetic hemochromatosis from central and western Sweden, in: Proceedings of the International Symposium on Iron in Biology and Medicine, Saint-Malo, June 16-20, 1997, p. 253.
57. Milman N., Graudal N., Nielsen L., Fenger K. HLA determinants in 70 Danish patients with idiopathic haemochromatosis. Clin. Genet. 33:1998;286-292.
58. Ajioka R., Jorde L., Gruen J., et al. Haplotype analysis of hemochromatosis evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes . Am. J. Hum. Genet. 60:1997;1439-1447.
59. Thomas W., Fullan A., Loeb D., et al. A haplotype and linkage disequilibrium analysis of the hereditary hemochromatosis gene region. Hum. Genet. 102:1998;517-525.
60. Merryweather-Clarke A., Pointon J., Jouanolle A., Rochette J., Robson K. Geography of HFE C282Y and H63D mutations. Gene Test. 4:2000;183-198.
61. Motulsky A. Genetics of hemochromatosis. N. Engl. J. Med. 301:1979;1291-1292.
62. Datz C., Haas T., Rinner H., et al. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women a protective role against iron deficiency . Clin. Chem. 44:1998;2429-2432.